/2561 November 12, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q3/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
ที่ กบร No. Kor Bor Ror. 019/2018 November 12, 2018 President The Stock Exchange of Thailand Re : Inter-transaction of purchasing assets by subsidiary companies, and transaction of subsidiary company
Translation CEN 034-2018 November 13, 2018 Subject : Management Discussion and Analysis for quarter 3-2018 To : The Manager and President The Stock Exchange of Thailand Business operation for 3
November 14, 2019 Re: Clarification of the operating results of company and its subsidiaries for the three month period end March 31, 2019 To: President The Stock Exchange of Thailand K.C. Property
November 14, 2019 Re: Clarification of the operating results of company and its subsidiaries for the six months period end of June 30, 2019 To: President The Stock Exchange of Thailand K.C. Property
analysis for the three-month period ended September 30, 2019 To: Director and Manager of the Stock Exchange of Thailand Referring to the submission of reviewed financial statements for quarter 3/2019 of Wiik
1/4 August 13, 2020 Re: Clarification of the operating results of company and its subsidiaries for the six months period end June 30, 2020 To: President The Stock Exchange of Thailand K.C. Property
Exchange of Thailand The Board of Directors’ Meeting of Ladprao General Hospital Public Company Limited (the “Company”), No.4/2020, held on August 14, 2020, has approved the financial statements of the
May 14, 2020 Re: Clarification of the operating results of company and its subsidiaries for the three months period end March 31, 2020 To: President The Stock Exchange of Thailand K.C. Property